XML 73 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-Based Compensation
12 Months Ended
Dec. 31, 2014
Share-Based Compensation [Abstract]  
Share-Based Compensation

Note 17. Share-Based Compensation 

 

The following tables set forth certain share-based compensation information for 2014, 2013, and 2012, respectively:

 

 

 

 

 

 

 

 

 

 

Years ended December 31,

 

 

2014

 

2013

 

2012

Expense relating to share grants (a)

 

$          3,761,000

 

$             4,108,000

 

$             3,903,000

Adjustments to reflect changes in market price of

 

 

 

 

 

 

Company's common stock

 

 -

 

 -

 

10,000 

Amounts capitalized

 

(230,000)

 

(407,000)

 

(352,000)

Total charged to operations  (b)

 

$          3,531,000

 

$             3,701,000

 

$             3,561,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average

 

 

 

 

Shares

 

grant date value

 

 

Unvested shares, December 31, 2013

 

3,690,000 

 

$                      4.89

 

 

Restricted share grants

 

133,000 

 

6.32 

 

 

Vested during period

 

(150,000)

 

5.80 

 

 

Forfeitures/cancellations

 

(7,000)

 

4.39 

 

 

Unvested shares, December 31, 2014

 

3,666,000 

 

$                      4.90

 

 

 

 

 

 

 

 

 

(a) 2012 includes expense relating to equity and liability awards, as discussed below.

(b) 2012 includes $362,000 applicable to accelerated vestings that are included in employee termination costs.

 

 

The 2012 Plan authorizes 4.5 million shares to be available for grant and sets the maximum number of shares that may be granted to a participant in any calendar year at 500,000.  At December 31, 2014,  1.6 million shares remained available for grants pursuant to the 2012 Plan and, at that date, there remained an aggregate of $8.6 million applicable to all grants and awards to be expensed over a weighted average period of 3.2 years.

 

During 2014, there were 133,000 time-based restricted shares granted, with a weighted average grant date fair value of $6.32 per share. During 2013, there were 584,000 time-based restricted shares granted with a weighted average grant date fair value of $5.65 per share. During 2012, in addition to shares issued to the Company’s President and Chief Executive Officer, as discussed below, there were 698,000 other time-based restricted shares granted with a weighted average grant date fair value of $4.75 per share.

 

The total fair values of shares vested during 2014, 2013, and 2012 were $943,000,  $1,863,000, and $2,126,000, respectively (the 2012 amount include $585,000, applicable to accelerated vestings).

 

In June 2011, the Company’s President and Chief Executive Officer was to receive restricted share grants totaling 2.5 million shares as provided in his employment agreement, one-half of which to be time-based, vesting upon the seventh anniversary of the date of grant (vesting on June 15, 2018), and the other half to be performance-based, to be earned if the total annual return on an investment in the Company’s common stock (“TSR”) is at least an average of 6.5% per year for the seven years ending June 15, 2018. An independent appraisal determined the value of the performance-based award to be $4.39 per share compared to a market price at the date of grant of $4.98 per share. As a result of a per-person limitation within the Company’s prior stock incentive plan, only 500,000 shares had been issued through June 2012, 1.5 million shares had been accounted for as an “equity award”, and 500,000 shares had been accounted for as a “liability award”. The values of the equity and liability awards were expensed on a straight-line basis over the vesting period. As specifically provided in the 2012 Plan, the 2.0 million shares previously designated as equity and liability awards were issued, with the liability award being reclassified to equity. Consistent with such awards to other recipients, dividends have been paid on all the shares, including the equity and liability award shares, with the dividends paid on the equity award shares treated as distributions to common shareholders and included in the statement of equity, and the dividends paid on the liability award shares treated as compensation and included in the statement of operations. In addition, with respect to the liability award, adjustments to reflect changes in the fair value of the award (based on changes in the market price of the Company’s common stock) were also charged to operations.